You are here

Article Text

Article menu
Download PDFPDF
Letter
Uptake of HIV testing in patients with a confirmed sexually transmitted infection
  1. S Day,
  2. D Lakhani,
  3. C Rodgers
  1. Department of Genitourinary Medicine, Guy’s and St Thomas’s Hospital, London, UK
  1. Correspondence to:
 Sara Day, Lydia Department, Department of Genitourinary Medicine, St Thomas’s Hospital, London SE1 7EH, UK;
 Sarah.Day{at}gstt.sthames.nhs.uk

https://doi.org/10.1136/sti.78.5.389-a

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    UK seroprevalence rates indicate that up to 50% of HIV positive patients in genitourinary medicine (GUM) clinics remain undiagnosed.1 HIV is mainly identified in high risk patient groups. Sexually transmitted infections other than HIV (STIs) have been shown to facilitate and be associated with enhanced HIV transmission.2 Risk assessment for HIV, therefore, should target patients with an STI or history of recurrent STIs as a high risk group.

    Targeting these patients to test for HIV at the time or 3 months after their STI diagnosis, is important as it will lengthen the “diagnosis interval” of patients testing HIV positive thereby conferring a better outcome, …

    View Full Text